Dr. Howard Steiner is an instructor of medicine at the Johns Hopkins School of Medicine. He has been practicing pulmonary and sleep consultative medicine since 1989. In his role as a diagnostician, he guides the evaluation and management of respiratory problems including infectious, malignant, allergic, autoimmune, and sleep-related disorders. He has been part-time faculty in the Johns Hopkins Pulmonary Division since 1991, is a Fellow in the American College of Chest Physicians, and mentors medical students, residents, and pulmonary fellows training at the Johns Hopkins Hospital. Contact for Research Inquiries 10755 Falls Road Pavilion I, Suite 200 Lutherville, MD 21093 Phone: (410) 583-7124 Selected Publications Lwebuga-Mukasa JS, Steiner H. Monoclonal antibody to rat lung Maclura Pomifera agglutinin (MPA) lectin binding glycoprotein localizes apically on rat and human type II pneumocytes and Clara cells. J Cell Biol 107:71a, 1989. Roberts PJ, McBean GJ, Steiner H, Kohler C, Schwarcz R. Lesioning Effects of Ibotenate in the immature rat brain and protection by 2-amino-7 phosphonoheptanoic acid. Soc Neurosci Abst 9:261, 1983. Steiner H, Ingbar DI. Mechanisms of lung injury and repair. In: Matthay RA, Matthay MA, Wiedemann HP eds. Annual Review of Pulmonary and Critical Care Medicine. Hanley & Belfus (Philadelphia, 1989), pp 205-223. Steiner H, Lwebuga-Mukasa JS. A549 cells display distinct functional and morphologic properties depending on their culture substratum. J Cell Biol 107:71a, 1989. Steiner H, Lwebuga-Mukasa JS. A549 cells produce a factor which is Mitogenic for human lung fibroblasts. Amer Rev Resp Dis 139:A492 1989. Steiner H, McBean GJ, Kohler C, Roberts PJ, Schwarcz R. Ibotenate Induced neuronal degeneration in immature rat brain. Brain Research 307:117-124, 1984. Dr. Steiner is rated as an Advanced provider by MediFind in the treatment of Pneumonia. His top areas of expertise are Bronchiectasis, Obstructive Sleep Apnea, Lung Metastases, and Interstitial Lung Disease.

Dr. Karthik Suresh is a pulmonary and critical care physician. His clinical interests include acute lung injury and critical care medicine. He also specializes in the diagnosis and management of immune-related lung injury, especially in the context of autoimmune conditions and chemotherapy/immunotherapy for cancer. Dr. Suresh is a member of the Hopkins immune-related adverse events (irAE) tox team. He also takes care of critically ill patients in the medical and oncology ICUs. He’s a firm faculty member for the Janeway Firm of the Osler Housestaff Medical Service and provides teaching to medical students, housestaff and fellows. Dr. Suresh is rated as an Advanced provider by MediFind in the treatment of Pneumonia. His top areas of expertise are Interstitial Lung Disease, Acute Interstitial Pneumonia, Pneumonia, and Lung Metastases.

Stacey-ann Brown is a Pulmonary Medicine provider in Lutherville, Maryland. Dr. Brown is rated as an Advanced provider by MediFind in the treatment of Pneumonia. Her top areas of expertise are Acute Interstitial Pneumonia, Interstitial Lung Disease, Hypersensitivity Pneumonitis, and Cholesterol Pneumonia.

Dr. Robin Avery is an infectious disease physician who joined the Johns Hopkins faculty in 2012, with two decades of experience in transplant infectious disease. She is a past chair of the American Society of Transplantation (AST) Infectious Disease Community of Practice, was a co-editor of the first edition of the AST ID Guidelines, and serves on a Guidelines Committee for the Infectious Disease Society of America (IDSA) on immunizations in the immunocompromised host. She was the founding head of the Transplant Infectious Disease Section at the Cleveland Clinic and served as the founding director of the Cleveland Clinic Transplant ID Special Fellowship, authoring a curriculum that served as the basis for curricula later endorsed by the AST and IDSA. Her clinical and research interests include pre-transplant donor and recipient evaluation, and prevention and treatment of post-transplant infections, particularly transplant-associated viruses, viral load monitoring, novel therapies for CMV, hypogammaglobulinemia, immunizations, and strategies for safer living post-transplant. She has a strong interest in patient education and co-authored the script for a video designed to educate patients on decreasing post-transplant infection risks. Dr. Avery is rated as an Advanced provider by MediFind in the treatment of Pneumonia. Her top areas of expertise are Cytomegalic Inclusion Disease, Cytomegalovirus Infection, COVID-19, and Sepsis.

Dr. Checkley specializes in intensive care medicine. He is an expert in the diagnosis and management of acute respiratory failure and the acute respiratory distress syndrome. He also has extensive experience in the management of other life-threatening conditions commonly seen in the medical intensive care unit, including septic shock, acute gastrointestinal bleeding, acute liver failure, among other critical conditions. Dr. Checkley earned his M.D. from Northwestern University and received his Ph.D. from Johns Hopkins University. He completed his internal medicine residency training at Emory University and fellowship training in pulmonary and critical care medicine at Johns Hopkins School of Medicine. His research interests include International lung health, epidemiology, mechanical ventilation and acute lung injury. Dr. Checkley has been recognized by the National Institute of Health with the 2007 Post-doctoral National Research Service Award and the 2009 Pathway to Independence Career Award. Dr. Checkley is rated as a Distinguished provider by MediFind in the treatment of Pneumonia. His top areas of expertise are Pneumonia, Chronic Obstructive Pulmonary Disease (COPD), Asthma, and Cerebral Hypoxia.

Dr. Wise is a pulmonary, critical care physician. He is an expert in the diagnosis and treatment of patients with obstructive lung disease, including those with asthma and COPD. He is a consultant for patients with scleroderma and interstitial lung disease. He has expertise in pulmonary physiology and lung function testing. Dr. Wise’s research focus is the conduct of multi-center clinical trials in airway diseases and related translational research. Dr. Wise is the co-director of the Pulmonary T32 Multi-disciplinary Training Program in Pulmonary Disease. Dr. Wise is rated as a Distinguished provider by MediFind in the treatment of Pneumonia. His top areas of expertise are Systemic Sclerosis (SSc), Interstitial Lung Disease, Acute Interstitial Pneumonia, and Sarcoidosis.

Dr. Danoff is an Assistant Professor in the Division of Pulmonary and Critical Care Medicine and Co-Director of the Hopkins Interstitial Lung Disease Clinic. She is a specialist in diseases causing fibrosis or scarring in the lung, particularly those associated with autoimmune diseases including myositis. Dr. Danoff is rated as a Distinguished provider by MediFind in the treatment of Pneumonia. Her top areas of expertise are Interstitial Lung Disease, Acute Interstitial Pneumonia, Pulmonary Fibrosis, Endoscopy, and Lung Transplant.

Ulrike Kirsten Buchwald is an infectious diseases and HIV physician who attended Medical School in Germany and completed training in internal medicine residency and infectious diseases at New York University. In 2010, she joined the University of Maryland School of Medicine, Division of Infectious Diseases and the Institute of Human Virology. Dr. Buchwald received training in anal cancer screening and high-resolution anoscopy (HRA) and started a dedicated anal cancer screening clinic known as the Anal Lesion Evaluation Research Treatment (ALERT) clinic at the University of Maryland. She was the director of the ALERT clinic and in 2017 co-founded the Maryland Consortium for Anal Cancer Screening (MCACS) with Dr. Joyce Jones, Johns Hopkins Department of Medicine, and colleagues from the Department of Colorectal Surgery, to strengthen clinical care and research for HPV-related anal disease. She joined the Division of Gastroenterology and Hepatology at Johns Hopkins in 2019 to build a multi-disciplinary team dedicated to anal cancer screening, and to increase access to high-resolution anoscopy services and HPV-related anal dysplasia treatment for high-risk patients in Baltimore and the region. Recent News Articles and Media Coverage Making Anal Cancer Screening a Priority for High-Risk Patients Hopkins Medicine. Dr. Buchwald is rated as an Experienced provider by MediFind in the treatment of Pneumonia. Her top areas of expertise are Strep Throat, Chronic Graft Versus Host Disease (cGvHD), Pneumonia, and Meningitis.

Dr. Sara Keller graduated from the Duke University School of Medicine in 2007. She completed her Master of Public Health in epidemiology in 2006 at the University of North Carolina at Chapel Hill. She then completed a residency in Internal Medicine in the Osler Medical Residency Training Program at the Johns Hopkins Hospital in 2010, a fellowship in Infectious Diseases at the University of Pennsylvania in 2012, and a fellowship in the University of Pennsylvania Centers for Healthcare Improvement and Patient Safety in 2013. She also completed a Master of Science in Health Policy at the University of Pennsylvania in 2013. She is an Assistant Professor in Infectious Diseases where she primarily sees patients at Johns Hopkins Green Spring Station and also attends on the inpatient infectious disease consult service at the Johns Hopkins Hospital. She serves as the Medical Director of the Johns Hopkins Hospital Outpatient Parenteral Antimicrobial Therapy (OPAT) Service. Dr. Keller is rated as an Experienced provider by MediFind in the treatment of Pneumonia. Her top areas of expertise are Asymptomatic Bacteriuria, Sepsis, Severe Acute Respiratory Syndrome (SARS), and COVID-19.

Shmuel Shoham, M.D. is Professor of Medicine at Johns Hopkins University School of Medicine. Dr. Shoham has over 20 years of experience in management of patients with invasive infections, and is the author or co-author of over 100 original articles, book chapters and topic reviews. He is a nationally recognized expert in infectious diseases of immunocompromised patients and his research explores diagnosis, prevention and treatment of infections in such patients. Dr. Shoham serves as a reviewer and expert consultant to multiple journals, professional societies, hospitals and government agencies in the US and numerous countries abroad. He is a member of professional guideline committees for the American Society of Transplantation (AST), the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and Infectious Diseases Mycoses Study Group (EORTC/MSG) and the National Comprehensive Cancer Network (NCCN). Dr. Shoham is the recipient of numerous awards including the American College of Physicians' (Washington, DC Chapter) laureate award, their highest honor. Dr. Shoham received his medical degree from Thomas Jefferson University (Philadelphia, PA) and medical residency and infectious diseases fellowship training at Boston University School of Medicine (Boston, MA). Dr. Shoham is rated as an Experienced provider by MediFind in the treatment of Pneumonia. His top areas of expertise are Meningitis, Cryptococcosis, Cytomegalovirus Infection, and Cytomegalic Inclusion Disease.

Mark Sulkowski, MD, is a Professor of Medicine at the Johns Hopkins University School of Medicine and the Director of the Division of Infectious Diseases at Johns Hopkins Bayview Medical Center. He also serves as the Medical Director of the Viral Hepatitis Center in the Divisions of Infectious Diseases and Gastroenterology/Hepatology in the Department of Medicine and is the Senior Associate Dean for Clinical Trials. He received his MD from Temple University School of Medicine, Philadelphia, PA (1992), pursued training in Internal Medicine at Duke University School of Medicine, Durham, NC (1995) and completed his Fellowship in Infectious Diseases (1998) at the Johns Hopkins University School of Medicine. Prof. Sulkowski has been the principal investigator for more than 120 clinical trials related to the management of viral hepatitis B and C in persons with and without HIV co-infection. He was the global principal investigator for more than a dozen trials, including the largest clinical trial of agents for the treatment of hepatitis C (New England Journal of Medicine, 2009) and the vanguard study of combination therapy with direct inhibitors of the HCV NS5A and NS5B non-structural proteins (New England Journal of Medicine, 2014). He is the past-chair of the Hepatitis Transformative Sciences Group of the National Institute of Health-funded adult AIDS Clinical Trials Group (ACTG) where he led translational studies of liver disease, namely hepatitis B and C virus. He is an elected member of the American Society for Clinical Investigation (2011) and the American Association of Physicians (2017). Prof. Sulkowski is a member of numerous professional societies including the American Association for the Study of Liver Diseases (AASLD), the European Association for the Study of the Liver (EASL), and the Infectious Diseases Society of America (IDSA). With more than 300 peer-reviewed articles, he is widely published with works in Annals of Internal Medicine, New England Journal of Medicine, JAMA, Clinical Infectious Diseases, Journal of Hepatology, and Hepatology. In 2017, 2018 and 2019, he was named as a Highly Cited Researcher (Clarivate Analytics) defined as the being in the top 1% of global researchers in 21 fields of the sciences and social sciences based on the number of citations for papers. As an invited lecturer, he has been frequently invited to present at major national and international medical congresses and has educated learners in more than 25 countries. Dr. Sulkowski is rated as an Experienced provider by MediFind in the treatment of Pneumonia. His top areas of expertise are Hepatitis C, Hepatitis, HIV/AIDS, and Hepatitis B.

Dr. Rameen J. Molavi is part-time on the medical faculty as an instructor in medicine in the division of General Internal Medicine within the Department of Medicine at the Johns Hopkins University School of Medicine. His area of clinical expertise is internal medicine. Dr. Molavi is also the managing physician and chair of Park Medical Associates, a member of Johns Hopkins Regional Physicians. He is the recipient of the 2025 Samuel P. Asper Award for excellence in medicine from the Maryland Chapter of the American College of Physicians. Dr. Molavi holds a B.A. in biology from Rice University in Houston, TX. He earned his M.D. at the Johns Hopkins University School of Medicine. He completed his internship and residency in categorical internal medicine at the Washington University School of Medicine Barnes-Jewish Hospital in St. Louis, MO. He began medical practice in Lutherville in 1999 and joined Park Medical Associates in 2009. His practice focus is on primary care for adults of all ages. Recent News Articles and Media Coverage Dr. Rameen Molavi: COVID-19 Testing Realities, WYPR (April 28, 2020) Samuel Asper Award, American College of Physicians (2025). Dr. Molavi is rated as an Experienced provider by MediFind in the treatment of Pneumonia. His top areas of expertise are Mesenteric Venous Thrombosis, Glucocorticoid-Remediable Aldosteronism, Familial Hypertension, and Hypertension.

Dr. Paul Auwaerter is a professor of medicine at the Johns Hopkins University School of Medicine. His areas of clinical expertise include Lyme disease, Epstein-Barr virus and fever of unknown origin. Dr. Auwaerter serves as the clinical director of the Division of Infectious Diseases. He is also the director of the Fisher Center for Environmental Infectious Diseases and the chief medical officer of the Point of Care-Information Technology (POC-IT) Center. He earned his M.D. from the Columbia University College of Physicians and Surgeons. His research interests include tick-borne diseases and point of care information technology. Dr. Auwaerter serves on the Clinical Compensation Subcommittee for the Johns Hopkins Department of Medicine. He was recognized with a Healthnetworks Service Excellence Award in 2014. He is a member of the American Society of Microbiology and the Infectious Diseases Society of America. Dr. Auwaerter is rated as an Experienced provider by MediFind in the treatment of Pneumonia. His top areas of expertise are Lyme Disease, Infectious Myocarditis, Babesiosis, and Osteomyelitis.

Tatyana Kushnir is a primary care provider, practicing in Family Medicine in Lutherville, Maryland. Dr. Kushnir is rated as a Distinguished provider by MediFind in the treatment of Pneumonia. Her top areas of expertise are Bronchitis, Acute Cystitis, Atypical Pneumonia, and Hospital-Acquired Pneumonia. Dr. Kushnir is currently accepting new patients.

Lisa Simonson is a primary care provider, practicing in Internal Medicine in Lutherville Timonium, Maryland. Dr. Simonson is rated as an Experienced provider by MediFind in the treatment of Pneumonia. Her top areas of expertise are Prerenal Azotemia, Familial Hypertension, Glucocorticoid-Remediable Aldosteronism, and Hypertension.

Patricia Savadel is a primary care provider, practicing in Internal Medicine in Lutherville Timonium, Maryland. Dr. Savadel is rated as an Experienced provider by MediFind in the treatment of Pneumonia. Her top areas of expertise are Sitosterolemia, Crohn's Disease, Postmenopausal Osteoporosis, and Osteoporosis.

Mohammad Rahnama is a primary care provider, practicing in Internal Medicine in Parkville, Maryland. Dr. Rahnama is rated as an Experienced provider by MediFind in the treatment of Pneumonia. His top areas of expertise are High Cholesterol, Familial Combined Hyperlipidemia, Xanthoma, and Cirrhosis.

Paul Gurbel is a Cardiologist in Baltimore, Maryland. Dr. Gurbel is rated as an Experienced provider by MediFind in the treatment of Pneumonia. His top areas of expertise are Acute Coronary Syndrome, Coronary Heart Disease, Heart Attack, Percutaneous Coronary Intervention (PCI), and Angioplasty.

Daniel Brodie is an Intensive Care Medicine specialist and a Pulmonary Medicine provider in Baltimore, Maryland. Dr. Brodie is rated as an Advanced provider by MediFind in the treatment of Pneumonia. His top areas of expertise are Acute Respiratory Distress Syndrome (ARDS), COVID-19, Respiratory Acidosis, Lung Transplant, and Embolectomy.

Dr. Cosgrove is a Professor of Medicine in the Division of Infectious Disease (ID) at Johns Hopkins University School of Medicine and has a joint appointment in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health. She is the Director of Research for the ID Fellowship Program and PI of the T32 training grant that supports ID fellow training. She serves as the Director of the Department of Antimicrobial Stewardship and an Associate Hospital Epidemiologist at The Johns Hopkins Hospital. Dr. Cosgrove’s research interests include the epidemiology and outcomes of antimicrobial resistance, the development of tools and programs to promote the rational use of antimicrobials, the prevention of hospital-acquired infections, and the epidemiology and management of S. aureus bacteremia. Early in her career, she recognized the critical need to study antimicrobial stewardship strategies and has led a series of outcomes studies over the past 20 years that have defined the practice of antimicrobial stewardship in the United States. Her recent research focuses on strategies for implementation of antimicrobial stewardship activities across all healthcare settings via a large, multi-center project including hospitals, long-term care facilities and ambulatory practices funded by the Agency for Healthcare Research and Quality, and approaches to improve how antibiotics are given via a randomized trial to compare intravenous and oral therapy for Gram negative bacteremia funded by PCORI. She is the PI of the Johns Hopkins Prevention Epicenter, a Centers for Disease Control and Prevention-funded program that integrates antimicrobial stewardship, healthcare epidemiology, human factors engineering, data science, and implementation science to address knowledge gaps and develop strategies to optimize patient safety by preventing transmission of pathogens and improving antibiotic use in diverse healthcare settings and patient populations. She is a past voting member of the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria. She is a Past President of the Society for Healthcare Epidemiology’s Board of Directors. Dr. Cosgrove received her undergraduate degree from Columbia College, her medical degree from Baylor College of Medicine, and her master of science degree in epidemiology from Harvard School of Public Health. She completed her postgraduate training in internal medicine at The Johns Hopkins Hospital and underwent subsequent training in ID at Beth Israel Deaconess Medical Center. Dr. Cosgrove is rated as an Advanced provider by MediFind in the treatment of Pneumonia. Her top areas of expertise are Sepsis, Methicillin-Resistant Staphylococcus Aureus (MRSA), Pneumonia, and Pseudomonas Stutzeri Infections.